Live tape
Top 8, mentions 7d9,735TSLA2,123 mentions▲ +0.05GOOGL1,364 mentions▲ +0.04CRWV1,308 mentions▲ +0.03SPCX1,163 mentions▲ +0.07NVDA1,133 mentions▲ +0.07QQQ1,036 mentions▲ +0.05NBIS845 mentions▲ +0.06META763 mentions▲ +0.05

Equity · Healthcare

CCRN

NASDAQ

Cross Country Healthcare, Inc.

$13.26 +0.11% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for CCRN to draw a line in its place.

Market cap $428.6M
52-week range $7.61 – $14.23
Avg volume 212.6K

as of Jul 20, 2026

CCRN insider trades

SEC Form 4

CCRN has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 21 July 2026.

Date Insider Type Shares Value
11 Mar 2026 McDonald Colin Patrick Chief Human Resources Officer Sell 6,200 $60K
09 Dec 2025 CASH W LARRY Buy 5,000 $41K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
21 Jul 2026 Allen Dwayne Director Other 31,289 $415K
21 Jul 2026 Ball Susan E General Counsel and Secretary Other 314,649 $4.17M
21 Jul 2026 Ball Susan E General Counsel and Secretary Award 72,872
21 Jul 2026 Bhamidipati Venkat Director Other 29,759 $394K
21 Jul 2026 Burns William J. Chief Financial Officer Other 440,595 $5.84M
21 Jul 2026 Burns William J. Chief Financial Officer Award 104,157
21 Jul 2026 CASH W LARRY Director Other 223,312 $2.96M
21 Jul 2026 FITZGERALD GALE S Director Other 194,249 $2.57M
21 Jul 2026 Nevin Janice Elizabeth Director Other 48,616 $644K
21 Jul 2026 Clark Kevin Cronin Chief Executive Officer Other 1,199,510 $15.89M
21 Jul 2026 Clark Kevin Cronin Chief Executive Officer Award 247,416
21 Jul 2026 Krug Marc S. Group President, Delivery Other 124,352 $1.65M

Showing the 12 most recent of 43 compensation filings in this window. The figures above count all of them.

CCRN reported financials

SEC EDGAR XBRL SEC EDGAR

CCRN reported revenue of $1.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$94.9M.

Figure Reported Period
Revenue $1.1B 31 Dec 2025 fiscal year
Net income −$94.9M 31 Dec 2025 fiscal year
Diluted EPS −$2.93 31 Dec 2025 fiscal year
Total assets $451.1M 31 Mar 2026 at period end
Total equity $312.8M 31 Mar 2026 at period end

CCRN earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 −$0.14 —
31 Dec 2025 FY 2025 −$2.56 —
30 Sep 2025 FY 2025 −$0.15 —
30 Jun 2025 FY 2025 −$0.20 —
31 Mar 2025 FY 2025 −$0.02 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CCRN institutional holders

SEC Form 13F SEC EDGAR

9 of the 45 institutional funds we track reported a CCRN position for the quarter ended 30 Jun 2026 — a combined $17.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management New position 912,378 $12.1M
Renaissance Technologies Trimmed −37.8% shares 152,683 $2.0M
Two Sigma Investments Added +69.8% shares 89,060 $1.2M
GAMCO Investors Added +240.4% shares 80,000 $1.1M
Man Group New position 28,313 $374K
AQR Capital Management Trimmed −53.9% shares 21,261 $281K
Marshall Wace Trimmed −96.3% shares 17,000 $225K
D. E. Shaw & Co. Trimmed −80.0% shares 14,397 $190K
Citadel Advisors Trimmed −96.4% shares 10,942 $145K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SEC EDGARValuation computed from SEC EDGAR filings